CMU researchers have published in Science a new 3D bioprinting method that brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
A team of researchers from Carnegie Mellon University has published a paper in Science that details a new technique allowing anyone to 3D bioprint tissue scaffolds out of collagen, the major structural protein in the human body. This first-of-its-kind method brings the field of tissue engineering one step closer to being able to 3D print a full-sized, adult human heart.
The technique, known as Freeform Reversible Embedding of Suspended Hydrogels (FRESH), has allowed the researchers to overcome many challenges associated with existing 3D bioprinting methods, and to achieve unprecedented resolution and fidelity using soft and living materials.
Each of the organs in the human body, such as the heart, is built from specialized cells that are held together by a biological scaffold called the extracellular matrix (ECM). This network of ECM proteins provides the structure and biochemical signals that cells need to carry out their normal function. However, until now it has not been possible to rebuild this complex ECM architecture using traditional biofabrication methods.
What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle.
Adam Feinberg, Professor, Biomedical Engineering and Materials Science & Engineering
“What we’ve shown is that we can print pieces of the heart out of cells and collagen into parts that truly function, like a heart valve or a small beating ventricle,” says Adam Feinberg, a professor of biomedical engineering (BME) and materials science & engineering, whose lab performed this work. “By using MRI data of a human heart, we were able to accurately reproduce patient-specific anatomical structure and 3D bioprint collagen and human heart cells.”
Over 4,000 patients in the United States are waiting for a heart transplant, while millions of others worldwide need hearts but are ineligible for the waitlist. The need for replacement organs is immense, and new approaches are needed to engineer artificial organs that are capable of repairing, supplementing, or replacing long-term organ function. Feinberg, who is a member of Carnegie Mellon’s Bioengineered Organs Initiative and the Next Manufacturing Center, is working to solve these challenges with a new generation of bioengineered organs that more closely replicate natural organ structures.
“Collagen is an extremely desirable biomaterial to 3D print with because it makes up literally every single tissue in your body,” explains Andrew Hudson, a BME Ph.D. student in Feinberg’s lab and co-first author on the paper. “What makes it so hard to 3D print, however, is that it starts out as a fluid—so if you try to print this in air it just forms a puddle on your build platform. So we’ve developed a technique that prevents it from deforming.”
The FRESH 3D bioprinting method developed in Feinberg’s lab allows collagen to be deposited layer-by-layer within a support bath of gel, giving the collagen a chance to solidify in place before it is removed from the support bath. With FRESH, the support gel can be easily melted away by heating the gel from room temperature to body temperature after the print is complete. This way, the researchers can remove the support gel without damaging the printed structure made of collagen or cells.
This method is truly exciting for the field of 3D bioprinting because it allows collagen scaffolds to be printed at the large scale of human organs. And it is not limited to collagen, as a wide range of other soft gels including fibrin, alginate, and hyaluronic acid can be 3D bioprinted using the FRESH technique, providing a robust and adaptable tissue engineering platform. Importantly, the researchers also developed open-source designs so that nearly anyone, from medical labs to high school science classes, can build and have access to low-cost, high-performance 3D bioprinters.
Looking forward, FRESH has applications in many aspects of regenerative medicine, from wound repair to organ bioengineering, but it is just one piece of a growing biofabrication field. “Really what we’re talking about is the convergence of technologies,” says Feinberg. “Not just what my lab does in bioprinting, but also from other labs and small companies in the areas of stem cell science, machine learning, and computer simulation, as well as new 3D bioprinting hardware and software.”
“It is important to understand that there are many years of research yet to be done,” adds Feinberg, “but there should still be excitement that we’re making real progress towards engineering functional human tissues and organs, and this paper is one step along that path.”
Learn more: 3D printing the human heart
The Latest on: 3D bioprinting
via Google News
The Latest on: 3D bioprinting
- Acoustic bioprinting technology helps introduce nerve cells into spherical cage structureon May 4, 2020 at 10:10 pm
Their grid openings are only a few micrometers in size, making them ideal for holding cells and allowing living tissue to grow in a very specific shape. This new field of research is called ...
- 3D Printing Medical Devices Market - Anticipated to Witness High Growth in the Near Futureon May 1, 2020 at 9:57 am
According to latest research report " 3D Printing Medical Devices Market by Technology (3DP, EBM, LBM, Photopolymerization and DD), Component (3D Printers, 3D Bioprinters, Material (Plastic, Metal, ...
- 3D Bioprinting Market to Face a Significant Slowdown in 2020, as COVID-19 Sets a Negative Tone for Investorson May 1, 2020 at 1:33 am
May 01, 2020 (MARKITWIRED via COMTEX) -- VALLEY COTTAGE, N.Y. - Spritam (levetiracetam) is the first treatment with 3D bioprinting that gained FDA approval and was developed by Aprecia ...
- RASTRUM™- the 3D Printer of Living Cells, Honored in Annual Awards by Leading Business Magazineon April 30, 2020 at 5:53 am
The RASTRUM™ 3D Bioprinter from Inventia Life Science gives medical researchers and biologists the ability to rapidly produce 3D tissues that closely resemble our human body. By ...
- Viscient Biosciences is Leveraging 3D Bioprinting for Drug Discoveryon April 29, 2020 at 12:49 am
The versatile biotechnology company, created a more faithful picture of specific human diseases by relying on human cells and a 3D reconstruction of the tissue to show the truest possible biology ...
- Engineer makes, gives 350 face shields to area hospitalson April 27, 2020 at 10:26 am
Trans demonstrates one of the 350 facial shields he has made with a 3D printer at home. by Len Lear Trans (“R.J.”) Lualhati, is a young (26) scientist ...
- 3D Cell Culture Market Report Segment to Witness Highest Growth Rate in Upcoming Yearson April 27, 2020 at 10:22 am
The 3D cell culture market is seeing a steady development because of the elements, as tremendous ventures by life science organizations for R&D, advancement of robotized enormous scale cell culture ...
- 3D Bioprinting Market Size Worth USD 1,923.02 Million at a CAGR of 24.59% By 2023on April 23, 2020 at 2:07 pm
Apr 23, 2020 (Heraldkeepers) -- 3D Bioprinting Market Size, Growth, Trends and Share Analysis By Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting ...
- San Diego BioTech company fighting coronavirus through 3D bioprintingon April 20, 2020 at 10:09 am
Viscient Biosciences combines 3D bioprinting with leading genomics technologies to discover and develop drugs. Viscient’s 3D models are more similar to real human tissue and can provide more ...
- U.S Magnetic Levitation 3D Bioprinting Market will take the highest jump during 2020-2025on April 16, 2020 at 1:23 am
"The Magnetic Levitation 3D Bioprinting Market 2020 Research Report investigates the industry thoroughly and offers a complete study on Magnetic Levitation 3D Bioprinting volume, market Share ...
via Bing News